40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.33%
Negative revenue growth while MTDR stands at 13.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.14%
Negative gross profit growth while MTDR is at 1.90%. Joel Greenblatt would examine cost competitiveness or demand decline.
-21.68%
Negative EBIT growth while MTDR is at 0.33%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-21.68%
Negative operating income growth while MTDR is at 0.33%. Joel Greenblatt would press for urgent turnaround measures.
-31.01%
Negative net income growth while MTDR stands at 0.94%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.16%
Negative EPS growth while MTDR is at 0.73%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-31.98%
Negative diluted EPS growth while MTDR is at 0.74%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
2.09%
Share count expansion well above MTDR's 0.13%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.25%
Diluted share count expanding well above MTDR's 0.12%. Michael Burry would fear significant dilution to existing owners' stakes.
32.49%
Dividend growth above 1.5x MTDR's 0.71%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-22.19%
Negative OCF growth while MTDR is at 32.26%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-58.30%
Negative FCF growth while MTDR is at 1960.34%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-25.11%
Negative 10Y revenue/share CAGR while MTDR stands at 353.24%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
93.79%
5Y revenue/share CAGR at 50-75% of MTDR's 185.48%. Martin Whitman would worry about a lagging mid-term growth trajectory.
261.15%
3Y revenue/share CAGR under 50% of MTDR's 887.64%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-11.46%
Negative 10Y OCF/share CAGR while MTDR stands at 307.04%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
32.40%
Below 50% of MTDR's 259.66%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
639.87%
3Y OCF/share CAGR above 1.5x MTDR's 332.90%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-72.83%
Negative 10Y net income/share CAGR while MTDR is at 207.13%. Joel Greenblatt sees a major red flag in long-term profit erosion.
268.40%
5Y net income/share CAGR above 1.5x MTDR's 160.37%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
107.99%
3Y net income/share CAGR 50-75% of MTDR's 145.38%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
3.60%
Below 50% of MTDR's 308.77%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
8.52%
Below 50% of MTDR's 111.08%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
65.24%
3Y equity/share CAGR at 50-75% of MTDR's 101.60%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-54.90%
Cut dividends over 10 years while MTDR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
346.01%
Dividend/share CAGR of 346.01% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
243.78%
3Y dividend/share CAGR of 243.78% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.56%
Firm’s AR is declining while MTDR shows 11.59%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
29.07%
Asset growth 1.25-1.5x MTDR's 23.35%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
15.60%
BV/share growth above 1.5x MTDR's 4.55%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
51.54%
Debt growth far above MTDR's 88.18%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
27.06%
SG&A growth well above MTDR's 19.09%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.